跳至主要内容
临床试验/IRCT20200105046010N110
IRCT20200105046010N110招募中Unknown

In-vivo Bioequivalence Study of Levodopa/Benserazide 125 mg HBS Capsules and Dispersible Tablets of The Test Drug (Norstor® 125 mg HBS Capsules and Dispersible Tablets, Pars Gita Darou, Iran) in Compared with The Reference Drug (Madopar® 125 mg HBS Capsules and Dispersible Tablets, Roche, Switzerland) In Iranian Healthy Volunteers

Pars Gita Daru0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • General Health (Liver, Heart, and Kidney)
  • Body Mass Index (18-28) kg/m^2
  • Informed consent
  • Age (18-55 years old)

排除标准

  • History of cardiovascular disease
  • History of liver and kidney disease
  • Alcohol and drug addiction
  • History of allergy to Levodopa/Benserazide

研究者

发起方
Pars Gita Daru

相似试验